sub field
AI / MLBiotechDrug DiscoveryLongevity
About
Alex Zhavoronkov is a longevity and AI-drug-discovery entrepreneur best known as founder, chairman, CEO, and CBO of Insilico Medicine. He is also a visible ecosystem convenor in aging science through ARDD and as a contributor to the Biomarkers of Aging Consortium. Public evidence also shows direct personal investing activity, including participation in Insilico's Series D and a seed investment in The Cat Health Company.
Areas of interest
longevityAI drug discoverygenerative AIaging biologybiomarkers of aginggerosciencehealthspanregenerative medicineaging economicsclinical-stage biotechdeeptech